Innovative Toxoplasmosis Diagnostic Technologies and Emerging Markets
The report contains 226 pages, 15 tables and presents a detailed analysis of the Toxoplasmosis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Toxoplasmosis definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:
Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.
Contains 226 pages and 15 tables
- Hospitals
- Commercial/Private Labs
- Physician Offices
- Public Health Labs
Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.
Contains 226 pages and 15 tables
I. INTRODUCTION
II. TOXOPLASMOSIS WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
B. Diagnostic Tests
C. Vaccines and Drugs
D. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
E. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
III. FRANCE: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
IV. GERMANY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
V. ITALY: TEST MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VI. JAPAN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VII. SPAIN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VIII. UK: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
IX. USA: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
X. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Enzo Biochem
Fujirebio
Gen-Probe
Hologic
ID Biomedical
Innogenetics/Solvay
Kreatech
Life Technology
Lonza
Nanogen/Elitech
Novartis Diagnostics
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac
Wako
II. TOXOPLASMOSIS WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
B. Diagnostic Tests
C. Vaccines and Drugs
D. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
E. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
III. FRANCE: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
IV. GERMANY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
V. ITALY: TEST MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VI. JAPAN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VII. SPAIN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VIII. UK: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
IX. USA: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
X. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Enzo Biochem
Fujirebio
Gen-Probe
Hologic
ID Biomedical
Innogenetics/Solvay
Kreatech
Life Technology
Lonza
Nanogen/Elitech
Novartis Diagnostics
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac
Wako
LIST OF TABLES
Major Companies Developing or Marketing Toxoplasmosis
Tests
France
Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
France
Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
Germany
Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
Germany
Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
Italy
Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
Italy
Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
Japan
Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
Japan
Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
Spain
Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
Spain
Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
U.K.
Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
Major Companies Developing or Marketing Toxoplasmosis
Tests
France
Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
France
Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
Germany
Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
Germany
Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
Italy
Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
Italy
Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
Japan
Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
Japan
Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
Spain
Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
Spain
Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
U.K.
Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier